348P Phase I study of liposomal formulation of eribulin (E7389-LF) in patients (pts) with advanced solid tumours: Primary results of dose-escalation part
Author:
N. Yamamoto,J. Sato,T. Koyama,S. Iwasa,A. Shimomura,S. Kondo,S. Kitano,K. Yonemori,Y. Fujiwara,K. Tamura,T. Suzuki,T. Takase,Y. Nishiwaki,K. Nakai,T. Shimizu
Publication:
Annals of Oncology
Copyright © 2019 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.